SAG
TWST icon

SageView Advisory Group’s Twist Bioscience TWST Stock Holding History

SageView Advisory Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14
Closed -$445 – 2299
2025
Q4 		$445 Buy
+14
New +$437 ﹤0.01% 2459
2024
Q2 		– Sell
-33,332
Closed -$307K – 770
2024
Q1 		$307K Buy
+33,332
New +$1.2M 0.02% 409

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SageView Advisory Group's TWST Position: Q1 2026 in Review

SageView Advisory Group sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 14 shares — an estimated $445 sold.

SageView Advisory Group first reported a position in TWST in Q1 2024 and held it in 2 quarters. The position peaked at $307K in Q1 2024. 281 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • SageView Advisory Group reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 14 Twist Bioscience shares in Q1 2026, an estimated $445.
  • SageView Advisory Group first reported a position in Twist Bioscience in Q1 2024 and held it in 2 quarters.
  • SageView Advisory Group's Twist Bioscience position peaked at $307K in Q1 2024.
  • 281 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.